North East and North Cumbria
ICS Formulary
ICS Formulary
1 Gastro-intestinal system
01-06-04 Osmotic laxatives
| Macrogol oral powder, Compound |
|
Formulary
|
Use the product with the lowest acquisition cost. |
 MHRA Drug Safety Update (April 2021): Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect when mixed, leading to an increased risk of aspiration |
|
| Phosphates |
|
Formulary
|
|
|
|
| Macrogol Movicol liquid® |
|
Formulary
|
Approved as a second line macrogol laxative for care home residents only. |
|
|
Links
- Guidelines for the Management of Adults with Asymptomatic Liver Blood Test Abnormalities
- MHRA Drug Safety Update (April 2021): Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect when mixed, leading to an increased risk of aspiration
- MHRA Drug Safety Update (April 2021): Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect when mixed, leading to an increased risk of aspiration
- NICE CG61: Irritable Bowel Syndrome
- NICE CG99: Constipation in children and young people
- North of Tyne, Gateshead and North Cumbria - Constipation Prescribing Guidelines
- North of Tyne, Gateshead and North Cumbria - Guidelines for Prescribing Trans Anal Irrigation as a Treatment for Chronic Constipation and Faecal Incontinence in Adults
- NTAG: Transanal irrigation (TAI) systems (Peristeen Plus®, Aquaflush®, and QuFora®) for neurogenic bowel dysfunction, chronic constipation and chronic faecal incontinence